메뉴 건너뛰기




Volumn 92, Issue 5, 2013, Pages 577-586

The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: Where do we stand?

Author keywords

AlloHSCT; Ferritin; Iron chelators; Iron overload

Indexed keywords

AMPHOTERICIN B; CYCLOSPORIN; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; FREE RADICAL; HEPCIDIN; HEPCIDIN AGONIST; IRON CHELATING AGENT; MINIHEPCIDIN; TACROLIMUS; TRANSFERRIN; UNCLASSIFIED DRUG;

EID: 84877925016     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1682-8     Document Type: Review
Times cited : (22)

References (80)
  • 1
    • 0031878699 scopus 로고    scopus 로고
    • Iron overload in bone marrow transplant recipients
    • 9707025 1:STN:280:DyaK1czntVGhsA%3D%3D 10.1038/sj.bmt.1701301
    • Strasser SI, Kowdley KV, Sale GE, McDonald GB (1998) Iron overload in bone marrow transplant recipients. Bone Marrow Transplant 22:167-173
    • (1998) Bone Marrow Transplant , vol.22 , pp. 167-173
    • Strasser, S.I.1    Kowdley, K.V.2    Sale, G.E.3    McDonald, G.B.4
  • 2
    • 0242636489 scopus 로고    scopus 로고
    • Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia
    • 14561992 1:CAS:528:DC%2BD3sXotFems70%3D 10.1038/sj.bmt.1704244
    • Butt NM, Clark RE (2003) Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia. Bone Marrow Transplant 32:909-913
    • (2003) Bone Marrow Transplant , vol.32 , pp. 909-913
    • Butt, N.M.1    Clark, R.E.2
  • 3
    • 58249133837 scopus 로고    scopus 로고
    • Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation
    • Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M (2009) Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15:195-204
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 195-204
    • Kataoka, K.1    Nannya, Y.2    Hangaishi, A.3    Imai, Y.4    Chiba, S.5    Takahashi, T.6    Kurokawa, M.7
  • 6
    • 34248383686 scopus 로고    scopus 로고
    • Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation
    • Armand P, Kim HT, Cutler CS,Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:4586-8
    • (2007) Blood , vol.109 , pp. 4586-4588
    • Armand, P.1    Kim, H.T.2    Cutler, C.S.3    Ho, V.T.4    Koreth, J.5    Alyea, E.P.6    Soiffer, R.J.7    Antin, J.H.8
  • 7
    • 58149142545 scopus 로고    scopus 로고
    • Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies
    • Kim YR, Kim JS, Cheong JW, Song JW, Min YH (2008) Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies. Acta Haematol 120:182-9
    • (2008) Acta Haematol , vol.120 , pp. 182-189
    • Kim, Y.R.1    Kim, J.S.2    Cheong, J.W.3    Song, J.W.4    Min, Y.H.5
  • 8
    • 33645717043 scopus 로고    scopus 로고
    • Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    • Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H,George JN (2006) Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:506-510
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 506-510
    • Kamble, R.T.1    Selby, G.B.2    Mims, M.3    Kharfan-Dabaja, M.A.4    Ozer, H.5    George, J.N.6
  • 10
    • 5044247615 scopus 로고    scopus 로고
    • Rust and corrosion in hematopoietic stem cell transplantation: The problem of iron and oxidative stress
    • Evens AM, Mehta J, Gordon LI (2004) Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 34:561-571
    • (2004) Bone Marrow Transplant , vol.34 , pp. 561-571
    • Evens, A.M.1    Mehta, J.2    Gordon, L.I.3
  • 11
    • 0032795872 scopus 로고    scopus 로고
    • Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis
    • 10455371 1:STN:280:DyaK1MzpsVOntg%3D%3D 10.1038/sj.bmt.1701885
    • Maertens J, Demuynck H, Verbeken EK, Zachée P, Verhoef GE, Vandenberghe P, Boogaerts MA (1999) Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 24:307-312
    • (1999) Bone Marrow Transplant , vol.24 , pp. 307-312
    • Maertens, J.1    Demuynck, H.2    Verbeken, E.K.3    Zachée, P.4    Verhoef, G.E.5    Vandenberghe, P.6    Boogaerts, M.A.7
  • 12
    • 33646049725 scopus 로고    scopus 로고
    • Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: A study of 367 myeloma patients
    • 16532017 1:CAS:528:DC%2BD28XjsFakurw%3D 10.1038/sj.bmt.1705340
    • Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F, Barlogie B, Anaissie EJ (2006) Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplant 37:857-864
    • (2006) Bone Marrow Transplant , vol.37 , pp. 857-864
    • Miceli, M.H.1    Dong, L.2    Grazziutti, M.L.3    Fassas, A.4    Thertulien, R.5    Van Rhee, F.6    Barlogie, B.7    Anaissie, E.J.8
  • 13
    • 79955702763 scopus 로고    scopus 로고
    • Hematopoietic stem cell transplantation for thalassemia
    • 21190532 1:CAS:528:DC%2BC3MXntFOis74%3D 10.2174/157488811795495413
    • Gaziev J, Lucarelli G (2011) Hematopoietic stem cell transplantation for thalassemia. Curr Stem Cell Res Ther 6:162-169
    • (2011) Curr Stem Cell Res Ther , vol.6 , pp. 162-169
    • Gaziev, J.1    Lucarelli, G.2
  • 14
    • 84863855662 scopus 로고    scopus 로고
    • Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation
    • 22248276 1:CAS:528:DC%2BC38Xltlaltrs%3D 10.4149/neo-2012-024
    • Sivgin S, Baldane S, Kaynar L, Kurnaz F, Pala C, Sivgin H, Ozturk A, Cetin M, Unal A, Eser B (2012) Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation. Neoplasma 59:183-190
    • (2012) Neoplasma , vol.59 , pp. 183-190
    • Sivgin, S.1    Baldane, S.2    Kaynar, L.3    Kurnaz, F.4    Pala, C.5    Sivgin, H.6    Ozturk, A.7    Cetin, M.8    Unal, A.9    Eser, B.10
  • 16
    • 67650478252 scopus 로고    scopus 로고
    • Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation
    • Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Weetenham J, Kalaycio M, Copelan E (2009) Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 146:310-6
    • (2009) Br J Haematol , vol.146 , pp. 310-316
    • Mahindra, A.1    Bolwell, B.2    Sobecks, R.3    Rybicki, L.4    Pohlman, B.5    Dean, R.6    Andresen, S.7    Weetenham, J.8    Kalaycio, M.9    Copelan, E.10
  • 17
    • 0026470429 scopus 로고
    • Contributions of heme and non-heme iron to human nutritions
    • 1581009 1:CAS:528:DyaK38XisFCnuro%3D 10.1080/10408399209527576
    • Carpenter CE, Mahoney AW (1992) Contributions of heme and non-heme iron to human nutritions. Crit Rev Food Sci Nutr 31:333-367
    • (1992) Crit Rev Food Sci Nutr , vol.31 , pp. 333-367
    • Carpenter, C.E.1    Mahoney, A.W.2
  • 18
    • 0028910942 scopus 로고
    • Sequential changes in serum iron and ferritin in patients undergoing high dose chemotherapy and radiation with autologous bone marrow transplantation: Possible implications for treatment related toxicity
    • 9101228 1:CAS:528:DyaK2MXjsFyhuro%3D 10.1016/0891-5849(94)E0145-9
    • Gordon LI, Brown SG, Tallman MS, Rademaker AW, Weitzman SA, Lazarus HM, Kelley CH, Mangan C, Rubin H, Fox RM (1995) Sequential changes in serum iron and ferritin in patients undergoing high dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Rad Biol Med 18:383-389
    • (1995) Free Rad Biol Med , vol.18 , pp. 383-389
    • Gordon, L.I.1    Brown, S.G.2    Tallman, M.S.3    Rademaker, A.W.4    Weitzman, S.A.5    Lazarus, H.M.6    Kelley, C.H.7    Mangan, C.8    Rubin, H.9    Fox, R.M.10
  • 19
    • 0016405032 scopus 로고
    • A clinical evaluation of serum ferritin as an index of iron stores
    • 4825851 1:STN:280:DyaE2c7lsFShsg%3D%3D 10.1056/NEJM197405302902201
    • Lipschitz DA, Cook JD, Finch CA (1974) A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290:1213-1216
    • (1974) N Engl J Med , vol.290 , pp. 1213-1216
    • Lipschitz, D.A.1    Cook, J.D.2    Finch, C.A.3
  • 20
    • 67651163966 scopus 로고    scopus 로고
    • Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes
    • 10.1182/asheducation-2008.1.166
    • Cazzola M, Della Porta MG, Malcovati L (2008) Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. Hematol Am Soc Hematol Educ Prog 2008:166-175
    • (2008) Hematol Am Soc Hematol Educ Prog , vol.2008 , pp. 166-175
    • Cazzola, M.1    Della Porta, M.G.2    Malcovati, L.3
  • 21
    • 0020035215 scopus 로고
    • Perspectives in iron metabolism
    • 7043270 1:CAS:528:DyaL38XktlOku7Y%3D 10.1056/NEJM198206243062504
    • Finch CA, Huebers H (1982) Perspectives in iron metabolism. N Engl J Med 306:1520-1528
    • (1982) N Engl J Med , vol.306 , pp. 1520-1528
    • Finch, C.A.1    Huebers, H.2
  • 22
    • 33750030695 scopus 로고    scopus 로고
    • Multi-center validation of the transferability of the magnetic resonance T2*technique for the quantification of tissue iron
    • Thalassemia International Federation Heart T2*Investigators 17018390 1:CAS:528:DC%2BD28XhtF2gsr%2FE
    • Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ, Thalassemia International Federation Heart T2*Investigators (2006) Multi-center validation of the transferability of the magnetic resonance T2*technique for the quantification of tissue iron. Haematologica 91(10):1388-1391
    • (2006) Haematologica , vol.91 , Issue.10 , pp. 1388-1391
    • Tanner, M.A.1    He, T.2    Westwood, M.A.3    Firmin, D.N.4    Pennell, D.J.5
  • 25
    • 54349087055 scopus 로고    scopus 로고
    • The role of liver biopsy in the workup of liver dysfunction late after SCT: Is the role of iron overload underestimated?
    • 18604240 1:CAS:528:DC%2BD1cXht1Cmtr7M 10.1038/bmt.2008.193
    • Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Karakan T, Akyol G (2008) The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? Bone Marrow Transplant 42:461-467
    • (2008) Bone Marrow Transplant , vol.42 , pp. 461-467
    • Sucak, G.T.1    Yegin, Z.A.2    Ozkurt, Z.N.3    Aki, S.Z.4    Karakan, T.5    Akyol, G.6
  • 26
    • 2642563691 scopus 로고    scopus 로고
    • Abnormal liver function tests following bone marrow transplantation: Aetiology and role of liver biopsy
    • 15075988 10.1097/00042737-200402000-00006
    • Ho GT, Parker A, MacKenzie JF, Morris AJ, Stanley AJ (2004) Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 16:157-162
    • (2004) Eur J Gastroenterol Hepatol , vol.16 , pp. 157-162
    • Ho, G.T.1    Parker, A.2    MacKenzie, J.F.3    Morris, A.J.4    Stanley, A.J.5
  • 27
  • 28
    • 0032913108 scopus 로고    scopus 로고
    • Quantitative study of the variability of hepatic iron concentrations
    • 10053034 1:CAS:528:DyaK1MXhvVWju78%3D
    • Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV (1999) Quantitative study of the variability of hepatic iron concentrations. Clin Chem 45:340-346
    • (1999) Clin Chem , vol.45 , pp. 340-346
    • Emond, M.J.1    Bronner, M.P.2    Carlson, T.H.3    Lin, M.4    Labbe, R.F.5    Kowdley, K.V.6
  • 29
    • 0038542268 scopus 로고    scopus 로고
    • SQUID biosusceptometry in the measurement of hepatic iron
    • 12768253
    • Sheth S (2003) SQUID biosusceptometry in the measurement of hepatic iron. Pediatr Radiol 33:373-377
    • (2003) Pediatr Radiol , vol.33 , pp. 373-377
    • Sheth, S.1
  • 30
    • 0021267364 scopus 로고
    • Some practical aspects of dual-energy CT scanning
    • 6704653 1:STN:280:DyaL2c7lsFehtg%3D%3D 10.1259/0007-1285-57-673-82
    • Dunscombe PB, Katz DE, Stacey AJ (1984) Some practical aspects of dual-energy CT scanning. Br J Radiol 57:82-87
    • (1984) Br J Radiol , vol.57 , pp. 82-87
    • Dunscombe, P.B.1    Katz, D.E.2    Stacey, A.J.3
  • 31
    • 56349142424 scopus 로고    scopus 로고
    • Value of dual energy computed tomography for detection of myocardial iron deposition in thalassaemia patients: Initial experience
    • 18768275 10.1016/j.ejrad.2008.07.014
    • Hazirolan T, Akpinar B, Unal S, Gümrük F, Haliloglu M, Alibek S (2008) Value of dual energy computed tomography for detection of myocardial iron deposition in thalassaemia patients: initial experience. Eur J Radiol 68:442-445
    • (2008) Eur J Radiol , vol.68 , pp. 442-445
    • Hazirolan, T.1    Akpinar, B.2    Unal, S.3    Gümrük, F.4    Haliloglu, M.5    Alibek, S.6
  • 33
    • 34247159083 scopus 로고    scopus 로고
    • Magnetic resonance imaging measurement of iron overload
    • 17414205 10.1097/MOH.0b013e3280d2b76b
    • Wood JC (2007) Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 14:183-190
    • (2007) Curr Opin Hematol , vol.14 , pp. 183-190
    • Wood, J.C.1
  • 38
    • 69849098029 scopus 로고    scopus 로고
    • Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation
    • 10.1182/blood-2009-03-212282
    • Maradei SC, Maiolino A, de Azevedo AM, Colares M, Bouzas LF, Nucci M (2009) Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 6(114):1270-1275
    • (2009) Blood , vol.6 , Issue.114 , pp. 1270-1275
    • Maradei, S.C.1    Maiolino, A.2    De Azevedo, A.M.3    Colares, M.4    Bouzas, L.F.5    Nucci, M.6
  • 39
    • 58149191493 scopus 로고    scopus 로고
    • Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation
    • 18762767 1:CAS:528:DC%2BD1MXhtVGktQ%3D%3D 10.1038/bmt.2008.262
    • Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42:799-805
    • (2008) Bone Marrow Transplant , vol.42 , pp. 799-805
    • Pullarkat, V.1    Blanchard, S.2    Tegtmeier, B.3    Dagis, A.4    Patane, K.5    Ito, J.6    Forman, S.J.7
  • 40
    • 34548754553 scopus 로고    scopus 로고
    • Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation
    • 17614303 10.1002/cncr.22909
    • Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT, Han X (2007) Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 110:1303-1306
    • (2007) Cancer , vol.110 , pp. 1303-1306
    • Kontoyiannis, D.P.1    Chamilos, G.2    Lewis, R.E.3    Giralt, S.4    Cortes, J.5    Raad, I.I.6    Manning, J.T.7    Han, X.8
  • 41
    • 34347388216 scopus 로고    scopus 로고
    • Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality
    • 17468772 1:STN:280:DC%2BD2szmtlGgtQ%3D%3D 10.1038/sj.bmt.1705690
    • Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR (2007) Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 40:63-70
    • (2007) Bone Marrow Transplant , vol.40 , pp. 63-70
    • Poutsiaka, D.D.1    Price, L.L.2    Ucuzian, A.3    Chan, G.W.4    Miller, K.B.5    Snydman, D.R.6
  • 42
    • 29744438595 scopus 로고    scopus 로고
    • Bone marrow transplantation in adults with thalassemia treatment and long-term follow-up
    • 16339666 10.1196/annals.1345.024
    • Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G (2005) Bone marrow transplantation in adults with thalassemia treatment and long-term follow-up. Ann NY Acad Sci 1054:196-205
    • (2005) Ann NY Acad Sci , vol.1054 , pp. 196-205
    • Gaziev, J.1    Sodani, P.2    Polchi, P.3    Andreani, M.4    Lucarelli, G.5
  • 45
    • 0021266776 scopus 로고
    • Transferrin in disease II: Defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection
    • 6375346 1:STN:280:DyaL2c3ivVenug%3D%3D
    • Hunter RL, Bennett B, Towns M, Vogler WR (1984) Transferrin in disease II: defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection. Am J Clin Pathol 81:748-853
    • (1984) Am J Clin Pathol , vol.81 , pp. 748-853
    • Hunter, R.L.1    Bennett, B.2    Towns, M.3    Vogler, W.R.4
  • 46
    • 0027377484 scopus 로고
    • Yersinia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature
    • 8214368 1:STN:280:DyaK2c%2FislKqtg%3D%3D
    • Blei F, Puder DR (1993) Yersinia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 15:430-434
    • (1993) Am J Pediatr Hematol Oncol , vol.15 , pp. 430-434
    • Blei, F.1    Puder, D.R.2
  • 47
    • 0029064378 scopus 로고
    • Listeria septicemia complicating bone marrow transplantation for Diamond-Blackfan syndrome
    • 7640184 1:STN:280:DyaK2MzmslCmsw%3D%3D 10.3109/08880019509029572
    • Lee AC, Ha SY, Yuen KY, Lau YL (1995) Listeria septicemia complicating bone marrow transplantation for Diamond-Blackfan syndrome. Pediatr Hematol Oncol 12:295-299
    • (1995) Pediatr Hematol Oncol , vol.12 , pp. 295-299
    • Lee, A.C.1    Ha, S.Y.2    Yuen, K.Y.3    Lau, Y.L.4
  • 48
    • 0038398797 scopus 로고    scopus 로고
    • Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron
    • 10.1016/S0928-8244(03)00109-3
    • Bonsdorff VL, Sahlstedt L, Ebeling F, Ruutu T, Parkkinen J (2003) Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron. FEMS Immunol Med Microbiol 37:45-51
    • (2003) FEMS Immunol Med Microbiol , vol.37 , pp. 45-51
    • Bonsdorff, V.L.1    Sahlstedt, L.2    Ebeling, F.3    Ruutu, T.4    Parkkinen, J.5
  • 49
    • 84861444296 scopus 로고    scopus 로고
    • Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)
    • 22051904 1:CAS:528:DC%2BC38Xlt1Wmsbg%3D 10.1007/s00277-011-1358-1
    • Sivgin S, Eser B, Bahcebasi S, Kaynar L, Kurnaz F, Uzer E, Pala C, Deniz K, Ozturk A, Cetin M, Unal A (2012) Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT). Ann Hematol 91:743-749
    • (2012) Ann Hematol , vol.91 , pp. 743-749
    • Sivgin, S.1    Eser, B.2    Bahcebasi, S.3    Kaynar, L.4    Kurnaz, F.5    Uzer, E.6    Pala, C.7    Deniz, K.8    Ozturk, A.9    Cetin, M.10    Unal, A.11
  • 50
    • 0035896642 scopus 로고    scopus 로고
    • Hepcidin, a urinary antimicrobial peptide synthesized in the liver
    • 11113131 1:CAS:528:DC%2BD3MXitFKhtbo%3D 10.1074/jbc.M008922200
    • Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810
    • (2001) J Biol Chem , vol.276 , pp. 7806-7810
    • Park, C.H.1    Valore, E.V.2    Waring, A.J.3    Ganz, T.4
  • 51
    • 33750133047 scopus 로고    scopus 로고
    • Regulation of iron metabolism by hepcidin
    • 16848710 1:CAS:528:DC%2BD28Xpt1Cltro%3D 10.1146/annurev.nutr.26.061505. 111303
    • Nemeth E, Ganz T (2006) Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26:323-342
    • (2006) Annu Rev Nutr , vol.26 , pp. 323-342
    • Nemeth, E.1    Ganz, T.2
  • 52
    • 73449106764 scopus 로고    scopus 로고
    • Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines
    • 19915946 1:CAS:528:DC%2BD1MXhsFClur%2FF 10.1007/s12185-009-0443-x
    • Kanda J, Uchiyama T, Tomosugi N, Higuchi M, Uchiyama T, Kawabata H (2009) Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines. Int J Hematol 90:545-552
    • (2009) Int J Hematol , vol.90 , pp. 545-552
    • Kanda, J.1    Uchiyama, T.2    Tomosugi, N.3    Higuchi, M.4    Uchiyama, T.5    Kawabata, H.6
  • 53
    • 10844258104 scopus 로고    scopus 로고
    • Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
    • 15514116 1:CAS:528:DC%2BD2cXhtVOjsL3K 10.1126/science.1104742
    • Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093
    • (2004) Science , vol.306 , pp. 2090-2093
    • Nemeth, E.1    Tuttle, M.S.2    Powelson, J.3    Vaughn, M.B.4    Donovan, A.5    Ward, D.M.6    Ganz, T.7    Kaplan, J.8
  • 54
    • 79955975367 scopus 로고    scopus 로고
    • Minihepcidins: Small peptides involved in disulfide exchange with ferroportin act as agonists
    • Preza GC, Ruchala P, Nemeth E, Ganz T (2010) Minihepcidins: small peptides involved in disulfide exchange with ferroportin act as agonists. FASEB J 24:1011
    • (2010) FASEB J , vol.24 , pp. 1011
    • Preza, G.C.1    Ruchala, P.2    Nemeth, E.3    Ganz, T.4
  • 56
    • 84859417866 scopus 로고    scopus 로고
    • The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders
    • 22160086 10.1182/asheducation-2011.1.538
    • Ganz T, Nemeth E (2011) The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program 2011:538-542
    • (2011) Hematology Am Soc Hematol Educ Program , vol.2011 , pp. 538-542
    • Ganz, T.1    Nemeth, E.2
  • 57
    • 84055190801 scopus 로고    scopus 로고
    • Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload
    • 22045566 1:CAS:528:DC%2BC3MXhs1ShsLnM 10.1172/JCI57693
    • Preza GC, Ruchala P, Pinon R, Ramos E, Qiao B, Peralta MA, Sharma S, Waring A, Ganz T, Nemeth E (2011) Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest 121:4880-4888
    • (2011) J Clin Invest , vol.121 , pp. 4880-4888
    • Preza, G.C.1    Ruchala, P.2    Pinon, R.3    Ramos, E.4    Qiao, B.5    Peralta, M.A.6    Sharma, S.7    Waring, A.8    Ganz, T.9    Nemeth, E.10
  • 58
    • 84868545645 scopus 로고    scopus 로고
    • Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
    • 22990014 1:CAS:528:DC%2BC38Xhs12gsrrP 10.1182/blood-2012-07-440743
    • Ramos E, Ruchala P, Goodnough JB, Kautz L, Preza GC, Nemeth E, Ganz T (2012) Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 120(18):3829-3836
    • (2012) Blood , vol.120 , Issue.18 , pp. 3829-3836
    • Ramos, E.1    Ruchala, P.2    Goodnough, J.B.3    Kautz, L.4    Preza, G.C.5    Nemeth, E.6    Ganz, T.7
  • 59
    • 77951745552 scopus 로고    scopus 로고
    • Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation- induced anemia
    • 20053755 1:CAS:528:DC%2BC3cXmtFylu78%3D 10.1182/blood-2009-09-245977
    • Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G (2010) Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation- induced anemia. Blood 115:3616-3624
    • (2010) Blood , vol.115 , pp. 3616-3624
    • Sasu, B.J.1    Cooke, K.S.2    Arvedson, T.L.3    Plewa, C.4    Ellison, A.R.5    Sheng, J.6    Winters, A.7    Juan, T.8    Li, H.9    Begley, C.G.10    Molineux, G.11
  • 60
    • 34447137331 scopus 로고    scopus 로고
    • Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
    • 17607365 1:CAS:528:DC%2BD2sXnvVans7Y%3D 10.1172/JCI31342
    • Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117:1933-1939
    • (2007) J Clin Invest , vol.117 , pp. 1933-1939
    • Babitt, J.L.1    Huang, F.W.2    Xia, Y.3    Sidis, Y.4    Andrews, N.C.5    Lin, H.Y.6
  • 61
    • 0037272767 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
    • UK MDS Guidelines Group 12542475 10.1046/j.1365-2141.2003.03907.x
    • Bowen D, Culligan D, Jowitt S, Kelsey S, Mufti G, Oscier D, Parker J, UK MDS Guidelines Group (2003) Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br J Haematol 120:187-200
    • (2003) Br J Haematol , vol.120 , pp. 187-200
    • Bowen, D.1    Culligan, D.2    Jowitt, S.3    Kelsey, S.4    Mufti, G.5    Oscier, D.6    Parker, J.7
  • 63
    • 80052893340 scopus 로고    scopus 로고
    • Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo
    • 21809371 10.1002/ajh.22104
    • Alessandrino EP, Angelucci E, Cazzola M, Della Porta MG, Di Bartolomeo P, Gozzini A, Malcovati L, Pioltelli P, Simona Sica S, Bosi A (2011) Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo. Am J Hematol 86:897-902
    • (2011) Am J Hematol , vol.86 , pp. 897-902
    • Alessandrino, E.P.1    Angelucci, E.2    Cazzola, M.3    Della Porta, M.G.4    Di Bartolomeo, P.5    Gozzini, A.6    Malcovati, L.7    Pioltelli, P.8    Simona Sica, S.9    Bosi, A.10
  • 64
    • 72649100945 scopus 로고    scopus 로고
    • Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: Quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy
    • 19766730 1:CAS:528:DC%2BC3cXhvFWrtb0%3D 10.1016/j.bbmt.2009.09.011
    • Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A (2010) Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Biol Blood Marrow Transplant 16:115-122
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 115-122
    • Busca, A.1    Falda, M.2    Manzini, P.3    D'Antico, S.4    Valfrè, A.5    Locatelli, F.6    Calabrese, R.7    Chiappella, A.8    D'Ardia, S.9    Longo, F.10    Piga, A.11
  • 65
    • 31344451655 scopus 로고    scopus 로고
    • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation
    • 16443512 10.1016/j.bbmt.2005.09.012
    • Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JL, Socié G (2006) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 12:138-151
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 138-151
    • Rizzo, J.D.1    Wingard, J.R.2    Tichelli, A.3    Lee, S.J.4    Van Lint, M.T.5    Burns, L.J.6    Davies, S.M.7    Ferrara, J.L.8    Socié, G.9
  • 66
    • 0030848104 scopus 로고    scopus 로고
    • Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients
    • 9242528 1:CAS:528:DyaK2sXkvVWhsbY%3D
    • Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, Galimberti M, Giardini C, Gaziev D, Polchi P (1997) Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 90:994-998
    • (1997) Blood , vol.90 , pp. 994-998
    • Angelucci, E.1    Muretto, P.2    Lucarelli, G.3    Ripalti, M.4    Baronciani, D.5    Erer, B.6    Galimberti, M.7    Giardini, C.8    Gaziev, D.9    Polchi, P.10
  • 67
    • 0031001278 scopus 로고    scopus 로고
    • Iron-chelating therapy and the treatment of thalassemia
    • 9028304 1:CAS:528:DyaK2sXptVGntg%3D%3D
    • Olivieri NF, Brittenham GM (1997) Iron-chelating therapy and the treatment of thalassemia. Blood 89:739-761
    • (1997) Blood , vol.89 , pp. 739-761
    • Olivieri, N.F.1    Brittenham, G.M.2
  • 70
    • 34547137681 scopus 로고    scopus 로고
    • Iron chelation and regulation of the cell cycle:2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion
    • 17429006 1:CAS:528:DC%2BD2sXot1emtLw%3D 10.1182/blood-2007-03-076737
    • Fu D, Richardson DR (2007) Iron chelation and regulation of the cell cycle:2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood 110:752-761
    • (2007) Blood , vol.110 , pp. 752-761
    • Fu, D.1    Richardson, D.R.2
  • 71
    • 34247373460 scopus 로고    scopus 로고
    • Iron chelation regulates cyclin D1 expression via the proteasome: A link to iron deficiency-mediated growth suppression
    • 17197429 1:CAS:528:DC%2BD2sXkvFCiu7o%3D 10.1182/blood-2006-10-047753
    • Nurtjahja-Tjendraputra E, Fu D, Phang JM, Richardson DR (2007) Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression. Blood 109:4045-4054
    • (2007) Blood , vol.109 , pp. 4045-4054
    • Nurtjahja-Tjendraputra, E.1    Fu, D.2    Phang, J.M.3    Richardson, D.R.4
  • 72
    • 29744468975 scopus 로고    scopus 로고
    • The design of orally active iron chelators
    • 16339660 1:CAS:528:DC%2BD28XotlKisA%3D%3D 10.1196/annals.1345.017
    • Hider RC, Zhou T (2005) The design of orally active iron chelators. Ann N Y Acad Sci 1054:141-154
    • (2005) Ann N y Acad Sci , vol.1054 , pp. 141-154
    • Hider, R.C.1    Zhou, T.2
  • 74
    • 0042943205 scopus 로고    scopus 로고
    • Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
    • 12763939 1:CAS:528:DC%2BD3sXntFartLY%3D 10.1182/blood-2002-10-3280
    • Cohen AR, Galanello R, Piga A, De Sanctis V, Tricta F (2003) Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood 102:1583-1587
    • (2003) Blood , vol.102 , pp. 1583-1587
    • Cohen, A.R.1    Galanello, R.2    Piga, A.3    De Sanctis, V.4    Tricta, F.5
  • 80
    • 79953853812 scopus 로고    scopus 로고
    • A phase 1 dose-escalation study: Safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload
    • 21173101 1:CAS:528:DC%2BC38Xhs1WnsLjL 10.3324/haematol.2010.034405
    • Rienhoff HY Jr, Viprakasit V, Tay L, Harmatz P, Vichinsky E, Chirnomas D, Kwiatkowski JL, Tapper A, Kramer W, Porter JB, Neufeld EJ (2011) A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload. Haematologica 96:521-525
    • (2011) Haematologica , vol.96 , pp. 521-525
    • Rienhoff, Jr.H.Y.1    Viprakasit, V.2    Tay, L.3    Harmatz, P.4    Vichinsky, E.5    Chirnomas, D.6    Kwiatkowski, J.L.7    Tapper, A.8    Kramer, W.9    Porter, J.B.10    Neufeld, E.J.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.